Journal of Cardiac Failure
Volume 15, Issue 6 , Pages 523-528, August 2009

Acute Left Ventricular Unloading in Dogs With Chronic Heart Failure: Continuous Aortic Flow Augmentation Versus Intra-Aortic Balloon Pumping

  • Hani N. Sabbah, PhD

      Affiliations

    • Departments of Medicine and Surgery, Henry Ford Hospital, Detroit, Michigan
    • Corresponding Author InformationReprint requests: Hani N. Sabbah, PhD, FACC, Director of Cardiovascular Research, Henry Ford Hospital, 2799 West Grand Boulevard, Detroit, Michigan 48202. Tel.: (313) 916-7360; Fax: (313) 916-3001.
  • ,
  • Mengjun Wang, MD

      Affiliations

    • Departments of Medicine and Surgery, Henry Ford Hospital, Detroit, Michigan
  • ,
  • Ramesh C. Gupta, PhD

      Affiliations

    • Departments of Medicine and Surgery, Henry Ford Hospital, Detroit, Michigan
  • ,
  • Sharad Rastogi, MD

      Affiliations

    • Departments of Medicine and Surgery, Henry Ford Hospital, Detroit, Michigan
  • ,
  • Itamar Ilsar, DVM

      Affiliations

    • Departments of Medicine and Surgery, Henry Ford Hospital, Detroit, Michigan
  • ,
  • Tony Viole, MS

      Affiliations

    • Orqis Medical, Inc., Lake Forest, California
  • ,
  • Robert Brewer, MD

      Affiliations

    • Departments of Medicine and Surgery, Henry Ford Hospital, Detroit, Michigan

Received 30 April 2008; received in revised form 5 November 2008; accepted 14 January 2009. published online 04 March 2009.

Abstract 

Background

Continuous aortic flow augmentation (CAFA) therapy with the Cancion System (Orqis Medical, Inc) was shown to effectively unload the left ventricle in dogs with chronic heart failure (HF). This study compared the extent of acute left ventricular (LV) unloading elicited by CAFA to that elicited by intra-aortic balloon counterpulsation (IABP) in normotensive dogs with coronary microembolization-induced HF.

Methods and Results

Seven HF dogs were studied with both CAFA and IABP in random order and 1 week apart. In both instances, active therapy was maintained for 4hours. The Cancion system was positioned using a dual femoral approach configuration with a constant pump flow of 250mL/min. In all dogs and with both devices, LV end-diastolic pressure (EDP), LV end-systolic volume (ESV), and LV ejection fraction (EF) were measured at baseline and at 2 and 4hours after instituting CAFA or IABP. Plasma samples obtained at the end of 4hours of therapy were used to measure a host of circulating biomarkers that included neurohormones, cytokines, and A-type and B-type natriuretic peptides. IABP had no significant effects on LVEDP, LVESV, and LVEF. In contrast, CAFA significantly decreased LVEDP and LVESV and increased LVEF. Compared with IABP, CAFA was accompanied by significant improvements in circulating levels of neurohormones, cytokines, and natriuretic peptides.

Conclusions

The results indicate that CAFA is more effective than IABP in achieving acute global LV unloading in dogs with chronic HF not complicated by ongoing myocardial ischemia or cardiogenic shock.

Key Words: Congestive heart failure, ventricular dilation, ventricular function, plasma biomarkers, ventricular unloading

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Supported, in part, by a grant from Orqis Medical, Inc. and by a grant from the National Heart, Lung, and Blood Institute PO1 HL074237-05

 Dr. Sabbah has a research grant from and is a member of the Scientific Advisory Board of Orqis Medical, Inc; Tony Viole is a full-time employee of Orqis Medical, Inc.

PII: S1071-9164(09)00017-7

doi:10.1016/j.cardfail.2009.01.003

Journal of Cardiac Failure
Volume 15, Issue 6 , Pages 523-528, August 2009